Logo - springer
Slogan - springer

Medicine - Internal Medicine | International Journal of Hematology

International Journal of Hematology

International Journal of Hematology

Editor-in-Chief: Akifumi Takaori-Kondo

ISSN: 0925-5710 (print version)
ISSN: 1865-3774 (electronic version)

Journal no. 12185

$99.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

2 Volume(-s) with 12 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Information for Authors

The journal welcomes original papers that contribute to the progress of hematology. Submissions from all countries are invited.

Revised February 13, 2017

Pre-submission Charges  

If the first author is not a member of the Japanese Society of Hematology, US $20 (Authors from Japan: ¥2000) pre-submission charge will be charged before the peer-review process can begin. After submission, we would send you an email referring to credit card payment. Charges cannot be refunded at any cost and the submission would not move on to peer review process until we confirm the completion of your payment.

Submission of Manuscripts 

Authors should submit their manuscripts using the journal's online submission system. Electronic submission substantially reduces the editorial processing and reviewing time and shortens overall publication time. Please go directly to the site https://www.editorialmanager.com/ijhm and upload all files associated with the manuscript following the instructions given on the screen. Use the Help option to see the most recently updated system requirements.
  • Author accounts
Authors entering the journal’s Editorial Manager site can either create a new account or use an existing one.When you have an existing account, use it for all your submissions; you can track their status on the same page.
If you have forgotten your username and password, please click the link “Send Username/Password” and enter your e-mail address. You will then receive an automatically generated e-mail with your username and password. Alternatively, please create a new account and then follow the instructions given on the screen.
  • Getting started
Once you have logged into your account, Editorial Manager will lead you through the submission process in an orderly, step-by-step process. If you cannot finish your submission in one visit, you can save a draft and re-enter the process later at the same point for that manuscript.
While submitting your electronic manuscript, you will be required to enter data about your manuscript. These include full title, author names and affiliations, and other information, as listed below under Manuscript preparation. Support for special characters is available.
  • Uploading files
Main Documents: Main documents of articles should be uploaded in rich text format (.rtf) or as Microsoft Word documents (.doc).
Tables: Use the table functions of your word processing program, not spreadsheets, to create tables. Tables may be uploaded separately from the main document or inserted into the main document. Tables and Figures should be uploaded separately from the main document or inserted into the main document.
Figures: Common graphic file formats such as GIF, JPEG, EPS, and TIFF are supported. Please upload figures that are satisfactory for the review process and for printing according to artwork guidelines described in the end of this instruction.
After the components of the article have been uploaded in this manner, the system will convert the files to PDF format. You can view the result of the conversion with Adobe Acrobat Reader. You will also be notified by e-mail that your submission was successful.
Click Help at any point during this process to view answers to frequently asked questions. If the total size of the files exceeds the file volume (10 MB) for online submission, reduce the resolution of large files for initial submission.
  • Keeping track
After submission, you may return and monitor the progress of your submission through the review process.

Types of publications 

Original articles, case reports, rapid communications, and review articles are accepted for consideration by the Editorial Board with the understanding that no substantial part of the paper has been submitted or published elsewhere. Authors are responsible for conforming to the guidelines contained in this Information for Authors. The Editorial Board reserves the right to make corrections to the text in the interest of clarity, consistency, and readability. Editorial decisions are final.
● Original articles should include the following sections: Abstract, Introduction, Materials and methods, Results, Discussion, Acknowledgments, and References. Original articles should be no longer than 5,600 words.
● Case reports should describe new findings that have a significant clinical impact on hematologists or that may alter the concept of a disease. Case reports of the following will not be accepted for publication: a description of a rare disease or condition without new findings to be added to previous reports; a combination of different diseases without new suggestive findings for hematological research; remarkable effects of already known treatments without suggestive data to explain the exceptional results. Case reports should be no more than 1,800 words in length.
● Rapid communications should be limited to 6 typed pages, including references, and 4 pages of tables or figures. Rapid communications report only important new observations of sufficient significance and urgency to warrant rapid publication. Sections may be combined (e.g., Introduction, Methods [or Patients], Results, Discussion). Request for consideration as a Rapid communication should be made in the author’s cover letter upon submission.
Such papers, if accepted, will be published in the next available print issue; and all articles, including Rapid communications, will be published in the Online First format on SpringerLink ahead of print publication.
● Images in hematology. Authors can submit for consideration an illustration (or, where appropriate, two or more related images) that is interesting, instructive, and visually attractive,with a few lines of explanatory text and usually one or two contributors. High-resolution (600 dpi for line art; 300 dpi for halftones or color images) digital files should be submitted. Due to space constraints, there are usually no references in the “Images” section. However, a single reference may be accepted at the discretion of the Images Editor if it appears essential to the contribution in question.
● Review articles generally are invited contributions, but suitable manuscripts may be submitted for this purpose. However, involvement of medical writers/researchers employed by the pharmaceutical industry are not permitted for review articles.
● Letters to the editor. Letters to the editor are comments on published research. They should not exceed 700 words, 3 references, and 1 figure/table, and should include an illustrative title, but no abstract or subheadings.

Editorial policies 

The International Journal of Hematology has adopted the Uniform Requirements for Manuscripts (URM) established by the International Committee of Medical Journal Editors (ICMJE). These requirements were developed "to help authors and editors in their mutual task of creating and distributing accurate, clear, easily accessible reports of biomedical studies," and are available from the ICMJE website (www.icmje.org). The Editors reserve the right to reject studies that do not demonstrate sufficient conformity with IJH editorial policies or with accepted standards for the conduct of biomedical research. The Editors may further retract published articles that are subsequently shown to have been conducted in violation of these principles.
  • Animal studies
Research using animals must be conducted in conformity with local laws and regulations and under the supervision of the animal welfare committee, or its equivalent, of the institute at which the research was conducted. In general, all research use of animals should conform to the "3 R" principles of replacement, reduction, and refinement, and should be designed to minimize pain and distress.
  • Authorship
All persons listed in the author byline must have made substantive contributions to the experimental design, the acquisition and/or analysis of research data, or the preparation of the manuscript, and must agree to accept responsibility for the aspects of the work with which they were involved. All persons who made contributions to the preparation of the manuscript must be acknowledged, including those whose contribution was solely writing assistance, and any support for such assistance must be disclosed. All authors must agree to the content of the manuscript and its submission to IJH. Disputes over authorship should be resolved prior to submission. Failure to resolve authorship disputes may result in publication delays or other editorial action.
  • Redundant or Duplicate Publication
When submitting a paper, an author should always make a full statement to the editor about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work. The author should alert the editor if the work includes subjects about whom a previous report has been published. Any such work should be referred to and referenced in the new paper. Copies of such material should be included with the submitted paper to help the editor decide how to deal with the matter. If redundant or duplicate publication is attempted or occurs without such notification, authors should expect editorial action to be taken. At the least, prompt rejection of the submitted manuscript should be expected. If the editor was not aware of the violations and the article has already been published, then a notice of redundant or duplicate publication will probably be published with or without the author’s explanation or approval.
  • Acceptable Secondary Publication
Secondary publication in the same or another language, especially in other countries, is justifiable, and can be beneficial, provided all of the following conditions are met:
● The authors have received approval from the editors of both journals; the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version.
● The priority of the primary publication is respected by a publication interval of at least one week (unless specifically negotiated otherwise by both editors).
● The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.
● The secondary version reflects faithfully the data and interpretations of the primary version.
● A footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part and states the primary reference. A suitable footnote might read: “This article is based on a study first reported in the [title of journal, with full reference].”
  • Conflict of interest
The IJH requires authors to disclose financial or other interests, at the personal or institutional level, which might be construed as potentially influencing the results of experiments, their interpretation, or description. In adherence to current global standards of practice formulated by the ICMJE, the Editors require all authors to submit a completed Uniform Disclosure Form (available at: http://www.icmje.org/coi_disclosure.pdf) at the time of submission. Information on potential conflict(s) of interest may be revealed to reviewers, or as a note in the published version of the article, at the Editors' discretion.
A summary of conflicts should be listed for each author on the page following the acknowledgment. If no conflict exists, authors should state:
● The authors declare that they have no conflict of interest. A summary of relevant information will be published with the manuscript.
  • Distribution of materials and other resources
Authors must be willing to distribute, in a timely and unencumbered manner, materials, data, and other resources relating to the work to other researchers for use in replicating, testing, or building on the reported findings. Such materials may include cells or cell lines, DNA, reagents, antibodies, strains of mutant mice, or other genetically altered organisms. Materials should be distributed free of charge, but it is acceptable to request payment for costs of maintenance and/or shipping.
  • Human subjects
When reporting research on human subjects, the work must comply with the principles of the most recent version of the Declaration of Helsinki (updated 2008; http://www.wma.net/en/30publications/10policies/b3/index.html). Authors should indicate that the study design was approved by a relevant local ethics committee and, where appropriate, that informed consent was obtained from all subjects.
  • Privacy and confidentiality
Identifying information of patients or human subjects, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication.
  • Registration of clinical trials
In adherence with the ICMJE uniform requirements and current practice standards for biomedical research, the IJH requires that all articles describing research in which human subjects have been prospectively assigned to intervention or control groups to study the cause-and-effect relationship between a clinical intervention and an outcome be registered with a not-for-profit, publicly accessible registry. This requirement only applies to the design and methodology of the trial; results are not required to be registered by the journal. Examples of public clinical trials registries include those administered by the World Health Organization (http://apps.who.int/trialsearch/) and the US National Institutes of Health (http://clinicaltrials.gov/).
  • Permissions:
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format.

Manuscript preparation 

The journal's language is English. British or American English spelling and terminology may be used, but should be followed consistently throughout the article. The form of manuscripts should adhere precisely to the following specifications. Authors whose native language is not English are required to seek the assistance of language services, or of a colleague who is a native English speaker and is familiar with the field of work before the submission.
  • Editing services for non-English speakers
The following organizations provide language services to non-native speakers of English. Please note that the International Journal of Hematology does not endorse, nor does it have any direct involvement with, any of the services listed; this information is provided solely for the convenience of authors for the International Journal of Hematology.
● Medical English Service http://www.med-english.com/ (Japanese Website only)
● Diacritech Language Editing Services http://www.languageedit.com/ (English Website only)
● Write Science Right http://www.writescienceright.com/ (English and Japanese Website)
● International Science Editing http://www.internationalscienceediting.com/ / (English Website)
http://www.internationalscienceediting.com/jp/ (Japanese Website)
  • Title page
Page 1 should contain the article title; author name(s); proposed running head not exceeding 45 characters and spaces, proposed type of manuscript (review article, original article, case report, rapid communication, letter to the editor); name of the department and institution in which the work was done; name, address, telephone and fax numbers, and e-mail address of the author to whom communications regarding the manuscript and reprints should be directed.
  • Abstract
Abstracts should be no longer than 200 words. The abstract should not contain any undefined abbreviations or reference citations.
  • Keywords
Please provide 3 to 5 keywords that can be used for indexing purposes.
  • Text formatting
For submission in Word
● Use 12-point Times Roman for text
● Use the automatic page-numbering function to number the pages
● Do not use field functions
● Use tab stops or other commands for indents, not the space bar
● Use the table function, not spreadsheets, to make tables
● Use the equation editor or MathType for equations
Note: If you use Word 2007, do not create the equations with the default equation editor but use MathType instead.
● Do not include tables or figures in main document. Please upload them separately on Editorial Manager.
  • Heading levels
Please use the decimal system of headings, with no more than three levels.
  • Conflict of interest
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. This note should be added in a separate section before the reference list. See the Editorial policies section for more information. If no conflict exists, authors should state: The authors declare that they have no conflict of interest.
  • References
The list of References should include only works that are cited in the text and that have been published or accepted for publication. Do not use footnotes or endnotes as a substitute for a reference list.
Citations in the text should be identified by numbers in square brackets.
Some examples:
1. Negotiation research spans many disciplines [3].
2. This result was later contradicted by Becker and Seligman [5].
3. This effect has been widely studied [1–3, 7].
  • List style
References should be listed at the end of the article. References should be numbered consecutively as they appear at their first mention in the text. For 6 or fewer authors, all should be listed; for 7 or more, only the first 6 should be listed, followed by et al.
1. Bhaskaram C, Reddy V. Cell-mediated immunity in iron- and vitamin-deficient children. Br Med J. 1979; 3:522-5.
2.Metcalf D. The hemopoietic colony-stimulating factors. Amsterdam: Elsevier Science; 1984.
3. Goldwasser E. Erythropoietin and differentiation. In: Cunningham D, Golwasser E, Watson J, Fox C, editors. Control of cellular division and development. New York: Alan R. Liss; 1981. p.487-94.
  • Unpublished data and personal communications
Do not include unpublished data or personal communications in the reference list. These may only be cited parenthetically in the text. If unpublished data are from the authors of the paper, cite in the text as unpublished data. If unpublished data are from contributors other than authors of the paper, the citation should include initial(s) and last names of all contributors and year. For personal communications, give initial(s) and last name(s) of all contributors and the month and year that the communication occurred, and indicate whether the communication was written or oral.
  • Abbreviations and acronyms
At its first appearance in the text, an abbreviation or acronym should be spelled out. Common abbreviations of units that need not be spelled out are: s, μm, μg, μL, min, mm, mg, mL, mM, h, cm, g, dL, M, mm3, kg, L, mEq, Bq, c/kg, Gy, etc.
  • SI units, numbers
Units of time should be written out in text, figure legends, and table footnotes and abbreviated only in tables. Use SI units for weights and measurements, degrees Celsius for temperature, and the 24-hour clock for times of day.
  • Product and manufacturers' names
In principle, generic names should be used; if trademarked names are used, the initial letters of the names should be capitalized. The name and location of manufacturers should be shown within parentheses.
  • Submission from Japan
The first author should be a member of the Japanese Society of Hematology at the acceptance stage of the manuscript, except for the student.
  • ESM
If electronic supplementary material (ESM) is submitted, it will be published as received from the author in the online version only.
ESM may consist of
● information that cannot be printed: animations, video clips, sound recordings
● information that is more convenient in electronic form: sequences, spectral data, etc.
● large original data, e.g., additional tables, illustrations, etc.
● If any ESM is supplied, the text must make specific mention of the material as a citation, similar to that of figures and tables (e.g., ". . . as shown in Animation 3.")
● For details on formats and other information, please follow the link (http://www.springer.com.12185) to the specific instructions for electronic supplementary material on the right
  • Artwork Guideline

Ethical Responsibilities of Authors 

This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation can be achieved by following the rules of good scientific practice, which include:
  • The manuscript has not been submitted to more than one journal for simultaneous consideration.
  • The manuscript has not been published previously (partly or in full), unless the new work concerns an expansion of previous work (please provide transparency on the re-use of material to avoid the hint of text-recycling (“self-plagiarism”)).
  • A single study is not split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (e.g. “salami-publishing”).
  • No data have been fabricated or manipulated (including images) to support your conclusions
  • No data, text, or theories by others are presented as if they were the author’s own (“plagiarism”). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks are used for verbatim copying of material, and permissions are secured for material that is copyrighted.
    Important note: the journal may use software to screen for plagiarism.
  • Consent to submit has been received explicitly from all co-authors, as well as from the responsible authorities - tacitly or explicitly - at the institute/organization where the work has been carried out, before the work is submitted.
  • Authors whose names appear on the submission have contributed sufficiently to the scientific work and therefore share collective responsibility and accountability for the results.
  • Authors are strongly advised to ensure the correct author group, corresponding author, and order of authors at submission. Changes of authorship or in the order of authors are not accepted after acceptance of a manuscript.
  • Adding and/or deleting authors and/or changing the order of authors at revision stage may be justifiably warranted. A letter must accompany the revised manuscript to explain the reason for the change(s) and the contribution role(s) of the added and/or deleted author(s). Further documentation may be required to support your request.
  • Requests for addition or removal of authors as a result of authorship disputes after acceptance are honored after formal notification by the institute or independent body and/or when there is agreement between all authors.
  • Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential proprietary data is excluded.
If there is a suspicion of misconduct, the journal will carry out an investigation following the COPE guidelines. If, after investigation, the allegation seems to raise valid concerns, the accused author will be contacted and given an opportunity to address the issue. If misconduct has been established beyond reasonable doubt, this may result in the Editor-in-Chief’s implementation of the following measures, including, but not limited to:
  • If the article is still under consideration, it may be rejected and returned to the author.
  • If the article has already been published online, depending on the nature and severity of the infraction, either an erratum will be placed with the article or in severe cases complete retraction of the article will occur. The reason must be given in the published erratum or retraction note. Please note that retraction means that the paper is maintained on the platform, watermarked "retracted" and explanation for the retraction is provided in a note linked to the watermarked article.
  • The author’s institution may be informed.

After acceptance 

During the production phase the following issues must be clarified:
  • Copyright
Copyright transfer: Authors will be asked to transfer copyright of the article to the Japanese Society of Hematology. This will ensure the widest possible protection and dissemination of information under copyright laws.
  • eOffprints
Upon publication the corresponding authors will receive a free eOffprint of their article.
  • Online First
An article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the article can also be cited by issue and page numbers. After online publication, changes can only be made in the form of an Erratum, which will be hyperlinked to the article.
  • Proof reading
Authors are informed by e-mail that a temporary URL has been created from which they can obtain their proofs. The proof should be used for checking for typesetting errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.
  • Page charges
Accepted manuscripts will be published subject to a fee of US $25 per published page (Authors from Japan: ¥3000 per published page).
  • Color in print
Color illustrations are free of charge.
Page and offprint (if any) charges will be separately charged to the corresponding author, except for solicited material. On request in unusual circumstances, the Editor-in-Chief may waive some or all of these charges.
All inquiries or correspondence of a general nature should be addressed to the Editorial Office.
Editorial Office
International Journal of Hematology
c/o The Japanese Society of Hematology
Maeda S.N. Bldg. 8F
518 Akinono-cho, Nijo-sagaru, Karasuma-dori,
Nakagyo-ku, Kyoto 604-0847, JAPAN
Tel: +81-75-231-5711
Fax: +81-75-231-5722
e-mail: ijh@jshem.or.jp

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2016 Impact Factor
  • 1.610
  • Aims and Scope

    Aims and Scope


    The International Journal of Hematology, the official journal of the Japanese Society of Hematology, has a long history of publishing leading research in hematology. The journal comprises articles that contribute to progress in research not only in basic hematology but also in clinical hematology, aiming to cover all aspects of this field, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy. The expanded [Progress in Hematology] section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. Reports on results of clinical trials are also included, thus contributing to the aim of fostering communication among researchers in the growing field of modern hematology. The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues. 

  • Submit Online
  • Information for Authors (html ver. Feb 1...

    Information for Authors


  • Information for Authors (PDF ver. Feb 13...
  • Author Submission Check List (pdf, 76 kB...
  • New editorial policies for IJH (pdf, 88 ...
  • Rights & Permissions
  • - Artwork
  • English Language Editing

    English Language Editing


  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to the Japanese Society of Hematology becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to the Japanese Society of Hematology effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author’s accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com”.

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the Japanese Society of Hematology. The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center’s RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on SpringerImages.com and click on the permissions link or go to copyright.com and enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.


    © The Japanese Society of Hematology

Alerts for this journal


Get the table of contents of every new issue published in International Journal of Hematology.